(Q50095736)
Statements
1 reference
Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma (English)
1 reference
19 October 2017
1 reference
scientific article published on 19 October 2017
No description defined